Condition : Rheumatoid Arthritis Interventions : Drug: Placebo; Drug: CNTO 6785 200 mg; Drug: CNTO 6785 200 mg; Drug: CNTO 6785 100 mg; Drug: CNTO 6785 50 mg; Drug: CNTO 6785 15 mg Sponsor : Janssen R...

Condition : Rheumatoid Arthritis Interventions : Drug: Placebo; Drug: CNTO 6785 200 mg; Drug: CNTO 6785 200 mg; Drug: CNTO 6785 100 mg; Drug: CNTO 6785 50 mg; Drug: CNTO 6785 15 mg Sponsor : Janssen R...

Condition : Osteoarthritis Intervention : Other: Observation Sponsor : South West Sydney Local Health District Recruiting - verified February 2014

Condition : Rheumatoid Arthritis Interventions : Drug: Placebo; Drug: CNTO 6785 200 mg; Drug: CNTO 6785 200 mg; Drug: CNTO 6785 100 mg; Drug: CNTO 6785 50 mg; Drug: CNTO 6785 15 mg Sponsors : Janssen...

Conditions : Osteoarthritis; Cardiovascular Risk Factors; Cardiovascular Disease; Metabolic Syndrome Interventions : Other: Cardiovascular risk factors diagnoses collection.; Other: History of cardiov...

Conditions : Osteoarthritis; Cardiovascular Risk Factors; Cardiovascular Disease; Metabolic Syndrome Interventions : Other: Cardiovascular risk factors diagnoses collection.; Other: History of cardiov...

Adipocytokines play an important role in joint inflammation in patients with knee osteoarthritis as measured by ultrasound and high sensitivity protein-C reactive. Adipocytokines could be the link bet...

have ≥6 swollen joints (from a 66-joint count) and ≥8 tender joints (from a 68-joint count) at Screening and at Baseline,

have ≥6 swollen joints (from a 66-joint count) and ≥8 tender joints (from a 68-joint count) at Screening and at Baseline,

Condition : Rheumatoid Arthritis Interventions : Drug: GLPG0634; Drug: Placebo Sponsors : Galapagos NV; Galapagos NV Recruiting - verified September 2013